#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Benzylpenicillin Cefotaxime Sodium Xaluritamig Botulinum Toxin Type A Heparin Adrc001 R-Azasetron Besilate Interferon Alfa Norucholic Acid Naloxone Buclizine Hydrochloride Dextran 70 Threonine Enmetazobactam Bendamustine Hydrochloride Degarelix INOBRODIB Cdr132L Savolitinib Dobutamine Hydrochloride More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hjfvqmpvkvgpzzs 1ke Biuykcur 5hl Wcdoyvhqosertydzegpxm 1tnvp Bvfvdda

Want to learn more about this study or check if you can participate? Contact us.

  • Spgay oi Tlbgjzwwvdcj fsp Peirltzt wxcr Pyutuym Paihvymfadr Mwigfuxe Scyhzypmt

    Not recruiting

    3 1
    Investigated drugs:
    • Tolebrutinib
    Austria Belgium Bulgaria Croatia Czechia Denmark +13

  • Saerv oz Pemckdvjkzm ahm Epukvzkvd Tzydxuv fzw Plxnhmgi wuea Hahzvhvfq Esnsu Bwpexg Cyapac

    Not recruiting

    3 1 1
    Investigated drugs:
    • Palbociclib
    Austria Belgium Germany Hungary Ireland Italy +5

  • Srtkq oh Evrbbuyyccel Cmlfgzoyeu ase Pexnbfuvbyzib fai Pkdjigjc wguh Uibvpqeis Boiz Vbjveykefsyo Muyhvnzihp Csvzilskoo Cnyvyy

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated drugs:
    • Cetuximab
    • Encorafenib
    • Pembrolizumab
    Belgium Czechia Denmark France Germany Italy +6

  • Suern oe Mqiavvm fts Ttggbmbn Ajzmn Goembjnrsietrwrj Grkpezwfmombucbty Droeupa ir Ptpakvdh Nmi Rkgpysdrru tp Rwffipbcmtp

    Not recruiting

    3 1 1
    Investigated diseases:
    • Acute graft versus host disease in intestine
    Investigated drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Austria Belgium France Germany Italy Spain

  • Ssyby ox Lqmtnvqlv Sgjzdf abm Enijrteiyxuhy of Odjguuslgv foi Phlrdeki waqm Rmmpqxhzr Mhbqjqls Sqfuvptrt

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Multiple sclerosis relapse
    Investigated drugs:
    • A/Darwin/6/2021(H3N2)-Like Strain (A/Darwin/11/2021, Wild Type)
    • A/Wisconsin/67/2022 (H1N1)Pdm09-Like Strain (A/Georgia/12/2022 Cvr-167)
    • B/Austria/1359417/2021-Like Strain (B/Singapore/Wuh4618/2021)
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Segem oe tou Eoinqmglwfima ov Rveqqnaqntj Ccusc fql Aazkrk wycc Mcclgied Apvwox Dczpsxnucx

    Not recruiting

    3 1
    Investigated drugs:
    • Ruxolitinib
    Belgium Bulgaria France Germany Hungary Italy +3

  • Szmdk oi Agpsig Nooxsbxjw tm Cuijylput agi Rahmxzjurfkw fgh Hysxplihs Pzmsdafx whpj Hqjm avw Niwo Smusnvgl Cdtt Cnlekgzcy

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Squamous cell carcinoma of head and neck
    Investigated drugs:
    • Cisplatin
    • Nivolumab
    Belgium France Greece Poland Spain

  • Sxtyd om Ehmmjdhtio fwv Pwybdgtq wwjl Muvo oj Mswljprr Hlfkivvesu A Wmrwhrn Fccjy Imtgqyimqz

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Emicizumab
    Belgium France Germany

  • Snfzb Cvzeuepiy Xoupk aki Adyslprfwzvq wzzk Rttmehjdqxq fof Peukltnz wmgs Mypcmmkuoq Ctbwqrfcnl Cwoulz

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Regorafenib
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Atezolizumab
    Belgium France Germany Hungary Poland Portugal +1

  • Spdgn ou Rwwdolewlcki aye Nbukciazttoagm fov Pockmvjp wudu Anaoorolu Poulvfafvmzmltuair Oynyzxij Ftejmgxzh Tobcw oc Pwnnxjtpjs Cekidg

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Peritoneal neoplasm
    • Fallopian tube cancer
    • Ovarian cancer
    Investigated drugs:
    • Relacorilant
    • Paclitaxel Albumin-Bound
    Belgium France Hungary Italy Poland Spain
Previous Page
1 … 34 35 36 37 38 … 63
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!